By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cangene Corporation 

104 Chancellor Matheson Road

Winnipeg  Manitoba  R3T 5Y3  Canada
Phone: 204-275-4200 Fax:



Company News
Emergent BioSolutions (EBS) Completes Acquisition Of Cangene Corporation (CC:CNJ) 2/21/2014 9:36:17 AM
Emergent BioSolutions (EBS) Shells Out $222 Million For Cangene Corporation (CC:CNJ) 12/12/2013 7:12:34 AM
FDA Lifts Clinical Hold on Cangene Corporation (CC:CNJ)'s Hemophilia Compound IB1001 7/30/2013 7:00:43 AM
Cangene Corporation (CC:CNJ) Withdraws MAA for Investigational Hemophilia Compound 6/14/2013 7:11:03 AM
FDA Approves Cangene Corporation (CC:CNJ)'s Treatment for Botulism 3/25/2013 7:46:07 AM
Ipsen (IPN.PA) and Inspiration Biopharmaceuticals Announce Closing of the IB1001 Sale to Cangene Corporation (CC:CNJ) 2/20/2013 10:31:59 AM
Celtic Pharma Welcomes the Results of the Sale Process of Inspiration Biopharmaceuticals' Hemophilia Assets to Cangene Corporation (CC:CNJ) 2/7/2013 9:47:32 AM
Ipsen (IPN.PA) Sells Hemophilia B Drug to Cangene Corporation (CC:CNJ) 2/6/2013 7:15:48 AM
Biotech Firm Cangene Corporation (CC:CNJ) Cuts 120 Jobs 1/6/2012 7:32:27 AM
Cangene Corporation (CC:CNJ) Names John A. Sedor as President and Chief Executive Officer 8/17/2011 5:46:10 AM